Furthermore, advancements in genomics have unveiled the intricate molecular subtypes of breast cancer, such as luminal A, luminal B, HER2-enriched, and triple-negative breast cancer (Fig. 2).43 Each subtype exhibits unique genetic signatures, clinical behaviours, and therapeutic responses. This evidence concerns the gene ERBB2 and breast cancer.